Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fennec Pharmaceuticals Q1 EPS $(0.04) Beats $(0.09) Estimate, Sales $8.75M Beat $8.18M Estimate

Author: Benzinga Newsdesk | May 13, 2025 05:05am
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.09) by 55.56 percent. This is a 109.76 percent decrease over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $8.75 million which beat the analyst consensus estimate of $8.18 million by 6.97 percent. This is a 65.52 percent decrease over sales of $25.38 million the same period last year.

Posted In: FENC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist